Huma

The company got an early boost after gaining the interest of Apple, which tasked Huma with developing a chemotherapy app for the Apple Watch. Since then, the company's various platforms are used by over 3,000 hospitals and clinics, with over 1.8+ million active healthcare users and 650,000+ research participants.

Its modular approach has proven highly advantageous, as it affords the company the ability to easily add new products and grow into new markets. Doctors use Huma's technology to monitor patient health across a range of rare and chronic diseases. It also offers symptom tracking, medication adherence, video consultations, and more.

Huma is also focusing on its humanitarian work such as donating resources to India and other countries. The company is well set for growth, especially following its acquisition of Alcedis.